Document is current
Any future updates will be listed below
-
Authors
Sayed, Shahin http://orcid.org/0000-0002-3472-511X
Fan, Shaoqi
Moloo, Zahir
Wasike, Ronald
Bird, Peter
Saleh, Mansoor
Shaikh, Asim Jamal
Figueroa, Jonine D.
Naidoo, Richard
Makokha, Francis W.
Gardner, Kevin
Oigara, Raymond
Njoroge, Faith Wambui
Magangane, Pumza
Mutebi, Miriam
Chauhan, Rajendra
Mwanzi, Sitna
Govender, Dhirendra
Yang, Xiaohong R.
-
Funding
Funding for this research was provided by:
Aga Khan University (Deans Fund)
GlaxoSmithKline (2011-GSK-ERI/GlaxoSmithKline/International.)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (intramural research program)
- License Information
-
More Information
Article History
Received: 25 February 2021
Accepted: 7 June 2021
First Online: 26 June 2021
Declarations
:
: This study was nested within a previously completed breast cancer study from Kenya [CitationRef removed]. Ethics approval was provided by the Research Ethics Committees of the Aga Khan University Hospital Nairobi (2016/REC-32 (v3) and the Faculty of Health Sciences Research Ethics Committee of the University of Cape Town (HREC 427/2016). The study was also permitted by the National Commission for Science Technology and Innovation, Kenya (Ref No: NACOSTI/P/19/72237/28785), License number: NACOSTI/P/19/993).
: Not applicable
: The authors declare that they have no competing interests.
